President Donald Trump’s announcement on Wednesday that pharmaceuticals imported to the U.S. would be exempt from tariff payments brought a sigh of relief from major drugmakers. But at the same time, industry leaders are bracing for the news that they
read moreUplizna is now the first FDA-approved treatment for immunoglobulin G4-related disease, a rare chronic inflammatory condition that widens the patient pool for the former Horizon Therapeutics drug. More: Amgen wins key rare disease nod for Uplizna, checking off one goal
read moreMassive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports. More: FDA staff cuts could disrupt drug reviews, putting agency's critical funding programs at risk: reports
read moreAs the RSV vaccine field grapples with a significantly reduced market size thanks to regulatory uncertainties, GSK and Pfizer have decided to lay to rest their patent feud. More: GSK, Pfizer resolve RSV patent feud amid vaccine market uncertainty Source:
read moreFunnyman Kenan Thompson is opening up about the not-so-funny experience of living with gastroesophageal reflux disease. More: ‘SNL’ star Kenan Thompson serves up a new campaign for Phathom’s Voquezna Source: fierce
read more© 1994 - 2025 B.M. Pharmaceuticals